OSTX
OS Therapies Incorporated
1.60$
-1.2%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6,332.4% | -99.7% | +0.0% | +48,574.7% | -99.6% | -50.0% | +16,089.1% | +11.0% | +290,421.5% | -100.0% | +0.0% | – | |
| – | – | – | – | – | – | – | -3.8% | -10.0% | +523,047.4% | -100.0% | -7.3% | – | |
| – | +233.6% | -37.4% | -3.7% | -246,286.1% | – | -195.5% | – | -28.6% | +568.1% | -43.4% | -59.2% | – | |
| – | – | -100.0% | – | – | – | +4,999,900.0% | +110.9% | +47.4% | +0.0% | -100.0% | – | – | |
| – | – | – | – | – | – | – | +68.6% | +159,045.2% | +0.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | +0.0% | – | – | – | |
| – | – | – | – | – | -100.0% | – | – | – | – | – | -100.0% | – | |
| – | +6.0% | -21.4% | +24.6% | +587,645.8% | -99.9% | -82.6% | +135.9% | +52.2% | -43.8% | +145.4% | -7.5% | – | |
| – | – | +167.2% | -108.7% | – | -99.8% | -169.7% | – | – | – | – | -210.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.